Trials / Completed
CompletedNCT04421040
Long-term Monitoring of Patients With Cardiac Amyloidosis With Implantable Event Monitors
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Researchers are gathering information to see if using an FDA approved implantable device can help with monitoring of your heart arrhythmias.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Biotronik Biomonitor 3 implant of device | The Biotronik Biomonitor 3 device will be implanted by the research team physician. |
| DEVICE | Biotronik Biomonitor 3 explant of device | The Biotronik Biomonitor 3 device will be removed from the patient by the research team physician. |
Timeline
- Start date
- 2020-10-07
- Primary completion
- 2023-03-22
- Completion
- 2023-03-22
- First posted
- 2020-06-09
- Last updated
- 2024-04-16
- Results posted
- 2024-04-16
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04421040. Inclusion in this directory is not an endorsement.